Megna Michael R: insider trades.
Megna Michael R reported 7 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($369K), across 1 company.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 1
- Companies
- 1
- Name as filed
- Megna Michael R
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | Officer · CHIEF ACCOUNTING OFFICER | 7 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-03 | Kiniksa Pharmaceuticals International, plc | S | 4,600 | $80.3 | 29,062 | Form 4 |
| 2026-09-01 | Kiniksa Pharmaceuticals International, plc | F | 5,531 | $79.28 | 33,662 | Form 4 |
| 2026-09-01 | Kiniksa Pharmaceuticals International, plc | M | 2,362 | — | 36,549 | Form 4 |
| 2026-09-01 | Kiniksa Pharmaceuticals International, plc | M | 2,558 | — | 34,187 | Form 4 |
| 2026-09-01 | Kiniksa Pharmaceuticals International, plc | M | 3,932 | — | 31,629 | Form 4 |
| 2026-09-01 | Kiniksa Pharmaceuticals International, plc | M | 2,644 | — | 39,193 | Form 4 |
| 2026-07-15 | Kiniksa Pharmaceuticals International, plc | A | 279 | $33.5 | 27,697 | Form 4 |
Questions
What stock did Megna Michael R buy or sell?
Megna Michael R reported 7 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($369K), across 1 company.
Is Megna Michael R the same person as other filers with this name?
This page covers SEC CIK 1464583 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/megna-michael-r-1464583.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.